Liposomes as vehicles for water insoluble platinum-based potential drug: 2-(4-(Tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II)KATUDEROVIC, Goran N; DIETRICH, Andrea; KOMMERA, Harish et al.European journal of medicinal chemistry. 2012, Vol 54, pp 567-572, issn 0223-5234, 6 p.Article

Heterogeneous optochemical VOC sensing layers selected by ESI-mass spectrometryCICCARELLA, G; SPADAVECCHIA, J; RELLA, R et al.Biosensors & bioelectronics. 2006, Vol 22, Num 3, pp 415-422, issn 0956-5663, 8 p.Conference Paper

Tumor inhibiting [1,2-bisfluorophenylethylenediamine] platinum-(II) complexes. I: SynthesisMÜLLER, R; GUST, R; JENNERWEIN, M et al.European journal of medicinal chemistry. 1989, Vol 24, Num 4, pp 341-348, issn 0223-5234, 8 p.Article

Circadian time-dependent tissue uptake of cisplatin (CDDP) and carboplatin (CBDCA) following repeated administrations : relationship with drug toxicities in miceBOUGHATTAS, N. A; FOURNIER, C; HECQUET, B et al.Annual review of chronopharmacology. 1990, Vol 7, pp 231-234, issn 0743-9539, 4 p.Conference Paper

Composés du Pt(II) à visée antitumorale, dérivés de l'ellipticine et de ses analogues = Antitumoral compounds of Pt(II), derivatives of ellipticine and its analoguesBENAZETH, S; BAZIN, D; VIOSSAT, B et al.Journal de chimie physique. 1989, Vol 86, Num 7-8, pp 1635-1642, issn 0021-7689, 8 p.Article

Adduct formation of cis-(NH₃)₂PtX₂ (X=Cl^-,I^-) with formamides and the crystal structures of cis-(NH₃)₂PtCl₂•(CH₃)₂NCHO. Application for the purification of the antitumor agent cisplatinRAUDASCHL, G; LIPPERT, B; HOESCHELE, J. D et al.Inorganica chimica acta. 1985, Vol 106, Num 3, pp 141-149, issn 0020-1693Article

Cis-dichlorodiammineplatinum(II) has a binding specificity for adjoining guanine basesINAGAKI, K; KIDANI, Y.Inorganica chimica acta. 1985, Vol 106, Num 4, pp 187-191, issn 0020-1693Article

Cyclopentadienyldifluorphosphin und Homologe als Liganden in cis-Dichloroplatin(II)-Komplexen ― Struktur von cis-(C₅Me₅PF₂)₂PtCl₂ und cis-(C₉H₇PF₂)[(C₉H₇)₃P]PtCl₂ (C₅Me₅=Pentamethylcyclopentadienyl, C₉H₇-Indenyl) = Cyclopentadienyldifluorophosphine and its homologues as ligands in eis-dichloroplatinum(II) complexes. Structure of cis-(C₅Me₅PF₂)₂PtCl₂ and cis-(C₉H₇PF₂)[(C₉H₇)₃P]PtCl₂ (C₅Me₅=pentamethylcyclopentadienyl, C₉H₇=indenyl)HEUER, L; BODE, U. K; JONES, P. G et al.Zeitschrift für Naturforschung. B, A journal of chemical sciences. 1989, Vol 44, Num 9, pp 1082-1092, issn 0932-0776, 11 p.Article

Paraplatin (carboplatin) current status and future prospects: proceedings/3rd European conference on clinical oncologyCARTER, S. K; HELLMANN, K.Cancer treatment reviews. 1985, Vol 12, issn 0305-7372, 152 p., suppl. AConference Proceedings

High-dose cisplatin in hypertonic salineOZOLS, R. F; CORDEN, B. J; JACOB, J et al.Annals of internal medicine. 1984, Vol 100, Num 1, pp 19-24, issn 0003-4819Article

Immunostimulatory effect of cis-diamine dichloroplatinum(II)RIHOVA, B; DROBNIK, J; RIHA, I et al.Immunology letters. 1984, Vol 8, Num 2, pp 57-60, issn 0165-2478Article

Dual electrode liquid chromatography-electrochemical detection (LCEC) for platinum-derived cancer chemotherapy agentsDING, H.-D; KRULL, I. S.Journal of liquid chromatography. 1983, Vol 6, Num 12, pp 2173-2194, issn 0148-3919Article

Dose-dependence and stability of cisplatin binding to tissue DNA and blood proteins in ratsMUSTONEN, R; TAKALA, M; LEPPALA, S et al.Carcinogenesis (New York. Print). 1989, Vol 10, Num 2, pp 365-368, issn 0143-3334, 4 p.Article

Analysis of hearing loss due to cis-diamminedichloroplatinum-IIVAN ZEIJL, L. G. P. M; CONIJN, E. A. J. G; RODENBURG, M et al.Archives of oto-rhino-laryngology. 1984, Vol 239, Num 3, pp 255-262, issn 0302-9530Article

The antitumour activity of some platinum (II) complexes of amino acidsCHARLSON, A. J; SHORTLAND, W. A.Inorganica chimica acta. 1984, Vol 93, Num 4, pp L67-L68, issn 0020-1693Article

In vitro binding of platinum compounds to human transferrinSYKES, T. R; STEPHENS-NEWSHAM, L. G; NOUJAIM, A. A et al.Research communications in chemical pathology and pharmacology. 1985, Vol 50, Num 3, pp 387-394, issn 0034-5164Article

The radiomimetic properties of a platinum drugBAROT, H. A; LAVERICK, M; NIAS, A. H. W et al.British journal of radiology. 1985, Vol 58, Num 685, pp 51-62, issn 0007-1285Article

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligandsYANYAN SUN; FEI LIU; SHAOHUA GOU et al.European journal of medicinal chemistry. 2012, Vol 55, pp 297-306, issn 0223-5234, 10 p.Article

Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum (II) complex linked to the minor groove binder stallimycinBARALDI, Pier Giovanni; MOJGAN AGHAZADEH TABRIZI; PAVANI, Maria Giovanna et al.Arzneimittel-Forschung. 2003, Vol 53, Num 2, pp 107-113, issn 0004-4172, 7 p.Article

EFFECT OF CISPLATIN ON THE PLASMA MEMBRANE PHOSPHATASE ACTIVITIES IN ASCITES SARCOMA-180 CELLS: A CYTOCHEMICAL STUDYAGGARWAL SK; NIROOMAND RAD I.1983; JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY; ISSN 0022-1554; USA; DA. 1983; VOL. 31; NO 2; PP. 307-317; BIBL. 60 REF.Article

HPLC SEPARATION AND COMPARATIVE TOXICITY OF SAXITOXIN AND ITS REACTION PRODUCTSRUBINSON KA.1982; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1982; VOL. 687; NO 2; PP. 314-320; BIBL. 18 REF.Article

TOXICITY OF CISPLATIN AND HYDROXYMALONATODIAMMINE PLATINUM (II) TOWARDS MOUSE BONE MARROW AND B16 MELANOMA IN RELATION TO DNA BINDING IN VIVOPERA MF JR; SESSFORD D; ROBERTS JJ et al.1982; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 13; PP. 2273-2278; BIBL. 16 REF.Article

Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitroMIKLASOVA, Natalia; FISCHER-FODOR, Eva; LÖNNECKE, Peter et al.European journal of medicinal chemistry. 2012, Vol 49, pp 41-47, issn 0223-5234, 7 p.Article

ANTIBODIES ELICITED AGAINST CIS-DIAMMINEDICHLOROPLATINUM(II)-MODIFIED DNA ARE SPECIFIC FOR CIS-DIAMMINEDICHLORO-PLATINUM(II)-DNA ADDUCTS FORMED IN VIVO AND IN VITROPOIRIER MC; LIPPARD SJ; ZWELLING LA et al.1982; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1982; VOL. 79; NO 21; PP. 6443-6447; BIBL. 23 REF.Article

Mechanisms for the renal secretion of cisplatinNELSON, J. A; SANTOS, G; HERBERT, B. H et al.Cancer treatment reports. 1984, Vol 68, Num 6, pp 849-853, issn 0361-5960Article